Terms: = Prostate cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2
27 results:
1. MicroRNA-181a restricts human γδ T cell differentiation by targeting Map3k2 and notch2.
Gordino G; Costa-Pereira S; Corredeira P; Alves P; Costa L; Gomes AQ; Silva-Santos B; Ribot JC
EMBO Rep; 2022 Jan; 23(1):e52234. PubMed ID: 34821000
[TBL] [Abstract] [Full Text] [Related]
2. Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant prostate cancer.
Hemani R; Patel I; Inamdar N; Campanelli G; Donovan V; Kumar A; Levenson AS
Cancer Prev Res (Phila); 2022 Feb; 15(2):87-100. PubMed ID: 34675064
[TBL] [Abstract] [Full Text] [Related]
3. Quality of Life After Bladder cancer: A Cross-sectional Survey of Patient-reported Outcomes.
Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
[TBL] [Abstract] [Full Text] [Related]
4. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/notch2 pathway via up-regulation of microRNA-143-3p.
Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
[TBL] [Abstract] [Full Text] [Related]
5. Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer.
Yang J; Xing H; Lu D; Wang J; Li B; Tang J; Gu F; Hong L
J Cell Mol Med; 2019 Jun; 23(6):4005-4018. PubMed ID: 30993885
[TBL] [Abstract] [Full Text] [Related]
6. NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells.
Farah E; Li C; Cheng L; Kong Y; Lanman NA; Pascuzzi P; Lorenz GR; Zhang Y; Ahmad N; Li L; Ratliff T; Liu X
J Biol Chem; 2019 May; 294(21):8543-8554. PubMed ID: 30940724
[TBL] [Abstract] [Full Text] [Related]
7. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
8. Unravelling disparate roles of NOTCH in bladder cancer.
Goriki A; Seiler R; Wyatt AW; Contreras-Sanz A; Bhat A; Matsubara A; Hayashi T; Black PC
Nat Rev Urol; 2018 Jun; 15(6):345-357. PubMed ID: 29643502
[TBL] [Abstract] [Full Text] [Related]
9. Perspectives on the discovery of notch2-specific inhibitors.
Dobranowski P; Ban F; Contreras-Sanz A; Cherkasov A; Black PC
Chem Biol Drug Des; 2018 Mar; 91(3):691-706. PubMed ID: 29078041
[TBL] [Abstract] [Full Text] [Related]
10. Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive prostate cancer Cells.
Mohamed AA; Tan SH; Xavier CP; Katta S; Huang W; Ravindranath L; Jamal M; Li H; Srivastava M; Srivatsan ES; Sreenath TL; McLeod DG; Srinivasan A; Petrovics G; Dobi A; Srivastava S
Mol Cancer Res; 2017 Oct; 15(10):1308-1317. PubMed ID: 28607007
[TBL] [Abstract] [Full Text] [Related]
11. Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells.
Santio NM; Landor SK; Vahtera L; Ylä-Pelto J; Paloniemi E; Imanishi SY; Corthals G; Varjosalo M; Manoharan GB; Uri A; Lendahl U; Sahlgren C; Koskinen PJ
Oncotarget; 2016 Jul; 7(28):43220-43238. PubMed ID: 27281612
[TBL] [Abstract] [Full Text] [Related]
12. prostate cancer Susceptibility in Men of African Ancestry at 8q24.
Han Y; Rand KA; Hazelett DJ; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Schumacher FR; Berndt SI; Wang Z; Xu J; Rohland N; Reich D; Tandon A; Pasaniuc B; Allen A; Quinque D; Mallick S; Notani D; Rosenfeld MG; Jayani RS; Kolb S; Gapstur SM; Stevens VL; Pettaway CA; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Chokkalingam AP; John EM; Murphy AB; Signorello LB; Carpten J; Leske MC; Wu SY; Hennis AJM; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Zheng SL; Witte JS; Casey G; Lubwama A; Pooler LC; Sheng X; Coetzee GA; Cook MB; Chanock SJ; Stram DO; Watya S; Blot WJ; Conti DV; Henderson BE; Haiman CA
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26823525
[TBL] [Abstract] [Full Text] [Related]
13. Not all NOTCH Is Created Equal: The Oncogenic Role of notch2 in Bladder cancer and Its Implications for Targeted Therapy.
Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation.
Zhang S; Chung WC; Wu G; Egan SE; Xu K
Neoplasia; 2014 Feb; 16(2):158-67. PubMed ID: 24709423
[TBL] [Abstract] [Full Text] [Related]
15. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and prostate cancer Cohort Consortium.
Machiela MJ; Lindström S; Allen NE; Haiman CA; Albanes D; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock S; Gaziano JM; Gapstur SM; Giovannucci E; Henderson BE; Jacobs EJ; Kolonel LN; Krogh V; Ma J; Stampfer MJ; Stevens VL; Stram DO; Tjønneland A; Travis R; Willett WC; Hunter DJ; Le Marchand L; Kraft P
Am J Epidemiol; 2012 Dec; 176(12):1121-9. PubMed ID: 23193118
[TBL] [Abstract] [Full Text] [Related]
16. Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2.
Roeseler DA; Sachdev S; Buckley DM; Joshi T; Wu DK; Xu D; Hannink M; Waters ST
PLoS One; 2012; 7(11):e47366. PubMed ID: 23144817
[TBL] [Abstract] [Full Text] [Related]
17. Reduction of pro-tumorigenic activity of human prostate cancer-associated fibroblasts using Dlk1 or SCUBE1.
Orr B; Grace OC; Brown P; Riddick AC; Stewart GD; Franco OE; Hayward SW; Thomson AA
Dis Model Mech; 2013 Mar; 6(2):530-6. PubMed ID: 23136397
[TBL] [Abstract] [Full Text] [Related]
18. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration.
Hahm ER; Chandra-Kuntal K; Desai D; Amin S; Singh SV
PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326
[TBL] [Abstract] [Full Text] [Related]
19. Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients.
Goode RR; Marshall SJ; Duff M; Chevli E; Chevli KK
Prostate; 2013 Jan; 73(1):48-53. PubMed ID: 22585386
[TBL] [Abstract] [Full Text] [Related]
20. Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration.
Kim SH; Sehrawat A; Sakao K; Hahm ER; Singh SV
PLoS One; 2011; 6(10):e26615. PubMed ID: 22039516
[TBL] [Abstract] [Full Text] [Related]
[Next]
